"From Innovation to Impact: Developing Clinical Diagnostics for Low-Resource Settings"

Jay Gerlach, Technology Solutions Strategic Program

Jay Gerlach is a Commercialization Associate for PATH's Technology Solutions Strategic Program. His work in biotech has focused on gene therapy for cancer, as well as identifying the mechanism of action and eliminating the side effects of validated pharmaceuticals. His work in global health started in Seattle Biomedical Research Institute where he worked on the malaria antigen discovery (MAD) project headed by Patrick Duffy.

PATH is an international nonprofit that creates sustainable, culturally relevant solutions by advancing health technologies and encouraging healthy behaviors.

Support provided by the School of Public Policy and others

contact: melissa_li@gatech.edu, jeremy.lim@gatech.edu

Food and Refreshments provided